Skip to ContentSkip to Navigation
About us Practical matters How to find us L. (Laura) Hesse


Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future

Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype

LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE

Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma

Subcutaneous and sublingual allergen specific immunotherapy in experimental models for allergic asthma

The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention

1,25(OH)2VitD3 supplementation enhances suppression of grass pollen-induced allergic asthma by subcutaneous and sublingual immunotherapy in a mouse model

A-Kinase Anchoring Proteins Diminish TGF-β1/Cigarette Smoke-Induced Epithelial-To-Mesenchymal Transition

Gene signatures from scRNA-seq accurately quantify mast cells in biopsies in asthma

Glycan modification of rPhl p5a leads to superior suppression of allergic inflammation in SCIT mouse model of allergic asthma

Read more